Clinical features relating to pneumococcal colony phase variation in hospitalized adults with pneumonia
Shuhei Ideguchi1,2, Kazuko Yamamoto1,2, Takahiro Takazono2
1First Department of Internal Medicine, Division of Infectious, Respiratory, and Digestive Medicine, University of the Ryukyus Graduate School of Medicine, Okinawa, Japan.
Abstract:
Background. Streptococcus pneumoniae is a major causative bacteria of pneumonia and invasive pneumococcal disease (IPD); however, the mechanisms underlying its severity and invasion remain to be defined. Pneumococcal colonies exhibit opaque and transparent opacity phase variations, which have been associated with invasive infections and nasal colonization, respectively, in animal studies. This study evaluated the relationship between the opacity of pneumococcal colonies and the clinical presentation of pneumococcal pneumonia.Methods. This retrospective study included adult patients hospitalized with pneumococcal pneumonia between 2012 and 2019 at four tertiary medical institutions. Pneumococcal strains from lower respiratory tract specimens were determined for their serotypes and microscopic colony opacity, and the association between the opacity phase and the severity of pneumonia was evaluated. Serotypes 3 and 37 with mucoid colony phenotypes were excluded from the study because their colony morphologies were clearly different.Results. A total of 92 patients were included. Most patients were older adults (median age: 72 years) and males (67 %), and 59 % had community-acquired pneumonia. Of the 92 patients, 41 (45 %), 12 (13 %), and 39 (42 %) patients had opaque, transparent, and mixed variants in their pneumococcal colony, respectively. The opaque and non-opaque pneumococcal variants had no statistically significant difference in patient backgrounds. Although the pneumonia severity index score did not differ between the opaque and non-opaque groups, the rate of bacteremia was significantly higher in the opaque group than in the non-opaque group. Serotype distribution was similar between the groups.Conclusions. Opaque pneumococcal variants may cause pneumonia and invasive diseases in humans. This study could help elucidate IPD, and opacity assessment may serve as a predictor for IPD.
Insights
Opaque variants of Streptococcus pneumoniae, a bacteria causing pneumonia, were linked to a higher rate of bacteremia in patients. This finding suggests opacity may predict invasive pneumococcal disease (IPD).
Area of Science:
- Microbiology and Infectious Diseases
- Bacterial Pathogenesis
- Clinical Medicine
Background:
- Streptococcus pneumoniae causes pneumonia and invasive pneumococcal disease (IPD), but invasion mechanisms are unclear.
- Pneumococcal colonies show opaque and transparent variations, linked to invasiveness and colonization in animal models.
- This study investigates the link between pneumococcal colony opacity and pneumonia severity in humans.
Purpose of the Study:
- To evaluate the association between pneumococcal colony opacity and the clinical presentation of pneumococcal pneumonia.
- To determine if colony opacity can serve as a predictor for invasive pneumococcal disease.
Main Methods:
- Retrospective study of 92 adult patients hospitalized with pneumococcal pneumonia (2012-2019).
- Analysis of pneumococcal strains from respiratory specimens for serotype and colony opacity.
- Exclusion of mucoid strains (Serotypes 3 and 37) due to distinct morphology.
Main Results:
- 45% of isolates were opaque, 13% transparent, and 42% mixed variants.
- No significant difference in patient demographics or pneumonia severity index between opaque and non-opaque groups.
- Significantly higher rate of bacteremia observed in patients with opaque pneumococcal variants compared to non-opaque variants.
Conclusions:
- Opaque pneumococcal variants are associated with increased bacteremia, suggesting a role in invasive disease.
- Colony opacity assessment may be a useful indicator for predicting invasive pneumococcal disease (IPD).
- Further research into opacity phase variation mechanisms can elucidate IPD pathogenesis.
More Related Videos
11:32Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
09:12Characterization of Inflammatory Responses During Intranasal Colonization with Streptococcus pneumoniae
Published on: January 17, 2014
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology
Pneumonia III: Complications and Assessment
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Stages of Infection
